Key Takeaways
- • Verdane leads a new funding round for Yazen, a Swedish digital healthcare provider focused on obesity treatment.
- • Yazen pairs weight-loss medication with continuous care from a multidisciplinary clinical team.
- • The round's size and valuation were not disclosed in the available reporting.
Summary
Verdane has led a new funding round for Yazen, a Swedish digital healthcare provider that treats obesity. The company's model combines prescription weight-loss medication with ongoing support from a multidisciplinary care team, positioning it within the growing market for digitally delivered obesity treatment.
The available reporting does not disclose the amount raised, the valuation, or the other participants in the round. It also does not detail Yazen's revenue, patient numbers, or expansion plans. Readers seeking those figures should consult the full original report or Verdane's own announcement.
The available reporting does not disclose the amount raised, the valuation, or the other participants in the round. It also does not detail Yazen's revenue, patient numbers, or expansion plans. Readers seeking those figures should consult the full original report or Verdane's own announcement.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.